Palatin Technologies Inc. (PTN)

[BesaoT35]

The market cap is $60 million. I think I saw recently that PTN has $60 million left from what AMAG gave to PTN to drop Vyleesi.

A valuation of a company at cash on hand should be some sort of floor fundamentally.

In the short term stocks are a popularity contest. Reverse stock splits are unpopular. In the long term stock valuation is a weighing process.

The DED treatment could actually work.

Vyleesi is FDA approved and works better in men than in women. Women are not a good market for an aphrodisiac but men would be a strong market.

It is hard I understand however to believe in a company that has never delivered for its shareholders in the past.